Capsaicin in the treatment of dermatologic disease - PubMed (original) (raw)

• PMID: 2438089

Capsaicin in the treatment of dermatologic disease

J E Bernstein. Cutis. 1987 Apr.

Abstract

Capsaicin cream is the first of a class of neuropeptide active agents to be introduced into dermatologic therapy. Capsaicin's effects appear primarily related to its ability to deplete the neuropeptide substance P from local sensory terminals in the skin. The use of capsaicin cream in the treatment of postherpetic neuralgia and psoriasis is discussed. I believe that capsaicin and other neuropeptide active agents may become important therapeutic modalities for the dermatologist in the near future.

PubMed Disclaimer

Similar articles

• Treatment of chronic postherpetic neuralgia with topical capsaicin. A preliminary study.
  Bernstein JE, Bickers DR, Dahl MV, Roshal JY. Bernstein JE, et al. J Am Acad Dermatol. 1987 Jul;17(1):93-6. doi: 10.1016/s0190-9622(87)70178-9. J Am Acad Dermatol. 1987. PMID: 3611458
• [The treatment of post-herpetic neuralgia using capsaicin ointment].
  van Horssen N. van Horssen N. Ned Tijdschr Geneeskd. 1990 Jun 2;134(22):1105-6. Ned Tijdschr Geneeskd. 1990. PMID: 2352566 Dutch. No abstract available.
• Capsaicin and substance P.
  Bernstein JE. Bernstein JE. Clin Dermatol. 1991 Oct-Dec;9(4):497-503. doi: 10.1016/0738-081x(91)90078-y. Clin Dermatol. 1991. PMID: 1726584 Review. No abstract available.
• Treatment of oral postherpetic neuralgia with topical capsaicin.
  Hawk RJ, Millikan LE. Hawk RJ, et al. Int J Dermatol. 1988 Jun;27(5):336. doi: 10.1111/j.1365-4362.1988.tb02364.x. Int J Dermatol. 1988. PMID: 2455696 No abstract available.
• [Capsaicin in pain therapy].
  Sokołowski P. Sokołowski P. Wiad Lek. 1994 Jul;47(13-14):527-32. Wiad Lek. 1994. PMID: 7716941 Review. Polish.

Cited by

• The effectiveness of topically applied capsaicin. A meta-analysis.
  Zhang WY, Li Wan Po A. Zhang WY, et al. Eur J Clin Pharmacol. 1994;46(6):517-22. doi: 10.1007/BF00196108. Eur J Clin Pharmacol. 1994. PMID: 7995318
• Structural determinant of TRPV1 desensitization interacts with calmodulin.
  Numazaki M, Tominaga T, Takeuchi K, Murayama N, Toyooka H, Tominaga M. Numazaki M, et al. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):8002-6. doi: 10.1073/pnas.1337252100. Epub 2003 Jun 13. Proc Natl Acad Sci U S A. 2003. PMID: 12808128 Free PMC article.
• Treatment of shingles and post-herpetic neuralgia.
  Jolleys JV. Jolleys JV. BMJ. 1989 Jun 10;298(6687):1537-8. doi: 10.1136/bmj.298.6687.1537. BMJ. 1989. PMID: 2503110 Free PMC article. Review. No abstract available.
• Structure and function of TRPV1.
  Tominaga M, Tominaga T. Tominaga M, et al. Pflugers Arch. 2005 Oct;451(1):143-50. doi: 10.1007/s00424-005-1457-8. Epub 2005 Jun 22. Pflugers Arch. 2005. PMID: 15971082 Review.
• Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review.
  Lindgren BR, Andersson RG. Lindgren BR, et al. Med Toxicol Adverse Drug Exp. 1989 Sep-Oct;4(5):369-80. doi: 10.1007/BF03259918. Med Toxicol Adverse Drug Exp. 1989. PMID: 2682132 Review.

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information